In contrast, the level of MDM4 protein in retinoblastoma cell lines and xenografts was up to 65 fold higher than human fetal retinae or a cell line (U2OS) that has MDM4 overexpression as a mechanism for inactivation of the p53 pathway. The gene discussed is TP53; the disease is retinoblastoma.